These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25498733)

  • 1. Clinical trials for multiple system atrophy.
    Galpern WR
    Lancet Neurol; 2015 Feb; 14(2):126-7. PubMed ID: 25498733
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: a randomised, placebo-controlled trial.
    Poewe W; Seppi K; Fitzer-Attas CJ; Wenning GK; Gilman S; Low PA; Giladi N; Barone P; Sampaio C; Eyal E; Rascol O;
    Lancet Neurol; 2015 Feb; 14(2):145-52. PubMed ID: 25498732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjugal parkinsonism: multiple system atrophy and Parkinson's disease.
    Miwa H; Kondo T
    Parkinsonism Relat Disord; 2010 Mar; 16(3):232. PubMed ID: 20061176
    [No Abstract]   [Full Text] [Related]  

  • 4. [A man with debilitating orthostatic hypotension].
    Nilsen KB; Berg-Hansen P; Berge E; Petterson MA; Gjesdal K
    Tidsskr Nor Laegeforen; 2012 Aug; 132(15):1758-61. PubMed ID: 22929944
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiple system atrophy: an update.
    Wenning GK; Geser F; Stampfer-Kountchev M; Tison F
    Mov Disord; 2003 Sep; 18 Suppl 6():S34-42. PubMed ID: 14502654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimally clinically important decline in the parkinsonian variant of multiple system atrophy.
    Krismer F; Seppi K; Wenning GK; Abler V; Papapetropoulos S; Poewe W
    Mov Disord; 2016 Oct; 31(10):1577-1581. PubMed ID: 27474888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rasagiline for the treatment of parkinsonism in Huntington's disease.
    Pérez-Pérez J; Martínez-Horta S; Pagonabarraga J; Carceller M; Kulisevsky J
    Parkinsonism Relat Disord; 2015 Mar; 21(3):340-2. PubMed ID: 25601128
    [No Abstract]   [Full Text] [Related]  

  • 8. The 'risus sardonicus' of multiple system atrophy.
    Wenning GK; Geser F; Poewe W
    Mov Disord; 2003 Oct; 18(10):1211. PubMed ID: 14534935
    [No Abstract]   [Full Text] [Related]  

  • 9. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease.
    Tison F; Yekhlef F; Chrysostome V; Balestre E; Quinn NP; Poewe W; Wenning GK
    Mov Disord; 2002 Jul; 17(4):701-9. PubMed ID: 12210859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Problems with dizziness].
    Bekkelund SI
    Tidsskr Nor Laegeforen; 2012 Aug; 132(15):1762. PubMed ID: 22929945
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diagnosis and therapy of multiple system atrophy].
    Wenning GK; Seppi K
    Praxis (Bern 1994); 2001 Jun; 90(23):1035-40. PubMed ID: 11447723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinsonism and dysautonomia: Multiple system atrophy?
    Albanese A; Cocco A; Milani P; Lalli S; Palladini G
    Parkinsonism Relat Disord; 2020 Aug; 77():146-149. PubMed ID: 31097298
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuroprotective effect of rasagiline in a rodent model of Parkinson's disease.
    Blandini F; Armentero MT; Fancellu R; Blaugrund E; Nappi G
    Exp Neurol; 2004 Jun; 187(2):455-9. PubMed ID: 15144871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does 1-(R)-aminoindan possess neuroprotective properties against experimental Parkinson's disease?
    Weinreb O; Bar-Am O; Prosolovich K; Amit T; Youdim MB
    Antioxid Redox Signal; 2011 Mar; 14(5):767-75. PubMed ID: 20919927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinsonism and dropped head: dystonia, myopathy or both?
    Savica R; Kumar N; Ahlskog JE; Josephs KA; Matsumoto JY; McKeon A
    Parkinsonism Relat Disord; 2012 Jan; 18(1):30-4. PubMed ID: 21873101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dropped head sign in parkinsonism.
    Yoshiyama Y; Takama J; Hattori T
    J Neurol Sci; 1999 Aug; 167(1):22-5. PubMed ID: 10500257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dopaminergic treatment and parkinsonian syndromes].
    Ghawche F; Durif F
    Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S83-6. PubMed ID: 12773892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [What is typical in atypical Parkinsonian syndromes?].
    Wallesch CW
    Fortschr Neurol Psychiatr; 2012 Sep; 80(9):491. PubMed ID: 22951770
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinically probable multiple system atrophy with predominant parkinsonism associated with myotonic dystrophy type 2.
    Lim SY; Wadia P; Wenning GK; Lang AE
    Mov Disord; 2009 Jul; 24(9):1407-9. PubMed ID: 19441131
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diagnostic criteria for Parkinson syndromes, expecting Parkinson's disease].
    Vidailhet M
    Rev Neurol (Paris); 2000; 156 Suppl 2 Pt 2():43-50. PubMed ID: 10916036
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.